Loading clinical trials...
Loading clinical trials...
1. Detect the expression of marker CD56 and CD11b in newly diagnosed cases of adult AML. 2. Study correlation between CD56 and CD11b expression with haematological parameters in cases of adult AML.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Assiut University
NCT02835222 · Untreated Adult Acute Myeloid Leukemia
NCT02159495 · Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, and more
NCT03226418 · Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, and more
NCT01822015 · Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), and more
NCT02096055 · Untreated Adult Acute Myeloid Leukemia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions